Explore more publications!

Chemicals Press Releases: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Chemicals Press Releases.

Press releases published on September 16, 2025

Capstone Infrastructure Corporation Successfully Commissions 192 MW Wild Rose 2 Wind Farm Alongside Offtakers Pembina Pipeline and City of Edmonton
ROHM Releases DOT-247: Integrated 2-in-1 SiC Molded Module for Industrial Applications
India Essential Oils Market Size Will Estimated to Reach USD 455.5 Million, Expanding at 7.6% CAGR by 2035 | TMR
Expert with Bayer Discusses the U.S. Launch of Aspirina Families with YourUpdateTV
Theratechnologies Receives Final Court Approval of Proposed Plan of Arrangement to Be Acquired by Future Pak
Theratechnologies reçoit l’approbation définitive du tribunal relativement au plan d’arrangement proposé visant son acquisition par Future Pak
Kane Biotech Completes U.S. FDA 510(k) Submission for revyve® Antimicrobial Wound Cleanser
Termination of Ruby Graphite Option Agreement
LGI Homes Kicks Off Annual “Make Your Move” National Sales Event
Teva to Host Conference Call to Discuss Data from the Completed Phase 3 SOLARIS Trial For Olanzapine LAI (TEV-‘749) on September 22, 2025 After Presentations at the Psych Congress Annual meeting
Weatherford Announces Tubular Running Services Contract Award with Petrobras
Evolution Petroleum Reports Fiscal Fourth Quarter and Full Year Fiscal 2025 Results
Snail Games 将与 Frozen Way Games 携《蜂巢:异星物语》亮相 2025 东京电玩展,加强全球市场布局
Snail Games 與 Frozen Way Games 聯袂出席 2025 年東京電玩展,以《Honeycomb: The World Beyond》鞏固全球市場地位
Flux Power Reports Fourth Quarter and Fiscal Year 2025 Financial Results
Coherent Announces High-Performance Wire Grid Polarizers for Isolators in Datacom Transceivers
Safe Bulkers, Inc. Announces Results of 2025 Annual Meeting of Stockholders
Espey Mfg. & Electronics Corp. reports fourth quarter and year-end results
Cytokinetics Announces Proposed Private Placement of $550.0 Million of Convertible Senior Notes
Kura Oncology Highlights Preclinical Data Demonstrating Potential of Farnesyl Transferase Inhibitors to Overcome Drug Resistance in Combination with Key Targeted Therapies Across Multiple Tumor Types

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions